ALKtALK with Dr. Alex Spria

Inside the Pipeline: TRI-611 and ALK+ Treatment Strategies

ALKtALK is thrilled to feature Alexander Spira, MD, PhD, FASCO, a medical oncologist at Virginia Cancer Specialists and member of our ALK Positive Scientific Advisory Board.

During this discussion, Dr. Spira will share insights and expertise on two clinical trials for ALK-positive patients—TRI-611 and Gilteritinib, and what these may mean for the ALK-positive community. He will also share his perspective as a leading thoracic oncologist involved in advancing clinical research and treatment strategies. Bring your questions, as this don’t miss session will include time for community Q&A.

ALKtALKs bring our community together with leading experts so patients and care partners can stay informed and empowered through shared knowledge and conversation, and this is one conversation you won’t want to miss!

This talk will be recorded and available on the ALK Positive YouTube channel for those unable to attend live. Whether you are newly diagnosed, in treatment, or supporting someone you love, we invite you to join this important ALKtALK and stay connected to the research shaping our community.

#ALKPositive #ALKtALK #LungCancerResearch #MoreResearchMoreTime